These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30755558)

  • 21. Clinical impact of an additional left ventricular lead in cardiac resynchronization therapy nonresponders: The V
    Bordachar P; Gras D; Clementy N; Defaye P; Mondoly P; Boveda S; Anselme F; Klug D; Piot O; Sadoul N; Babuty D; Leclercq C
    Heart Rhythm; 2018 Jun; 15(6):870-876. PubMed ID: 29288035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.
    Singh JP; Fan D; Heist EK; Alabiad CR; Taub C; Reddy V; Mansour M; Picard MH; Ruskin JN; Mela T
    Heart Rhythm; 2006 Nov; 3(11):1285-92. PubMed ID: 17074633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Echocardiographic and clinical response to cardiac resynchronization therapy in heart failure patients with and without previous right ventricular pacing.
    Gage RM; Burns KV; Bank AJ
    Eur J Heart Fail; 2014 Nov; 16(11):1199-205. PubMed ID: 25132044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P-wave morphology is associated with echocardiographic response to cardiac resynchronization therapy in MADIT-CRT patients.
    Holmqvist F; Platonov PG; Solomon SD; Petersson R; McNitt S; Carlson J; Zareba W; Moss AJ;
    Ann Noninvasive Electrocardiol; 2013 Nov; 18(6):510-8. PubMed ID: 24303967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies.
    Ciconte G; Ćalović Ž; McSpadden LC; Ryu K; Mangual J; Caporaso I; Baldi M; Saviano M; Cuko A; Vitale R; Conti M; Giannelli L; Vicedomini G; Santinelli V; Pappone C
    J Interv Card Electrophysiol; 2019 Mar; 54(2):141-149. PubMed ID: 30483980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of cardiac resynchronization therapy in patients with advanced congestive heart failure evaluated by real-time 3-dimensional echocardiography].
    Zhao YH; Zhang JY; Wei CH; Wang XQ; Zhang J; Xu Y; Gao CY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):668-73. PubMed ID: 24225238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of multisite left ventricular pacing via quadripolar lead improves acute haemodynamics and mechanical dyssynchrony assessed by radial strain speckle tracking: initial results.
    Osca J; Alonso P; Cano O; Andrés A; Miro V; Tello MJ; Olagüe J; Martínez L; Salvador A
    Europace; 2016 Apr; 18(4):560-7. PubMed ID: 26333378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy - a pilot study.
    Kuznetsov VA; Soldatova AM; Kasprzak JD; Krinochkin DV; Melnikov NN
    Cardiovasc Ultrasound; 2018 Oct; 16(1):24. PubMed ID: 30285762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of upgrading to His bundle pacing in chronically paced patients with left ventricular ejection fraction <50.
    Shan P; Su L; Zhou X; Wu S; Xu L; Xiao F; Zhou X; Ellenbogen KA; Huang W
    Heart Rhythm; 2018 Mar; 15(3):405-412. PubMed ID: 29081396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remote past left ventricular function before chronic right ventricular pacing predicts responses to cardiac resynchronization therapy upgrade.
    Chang PC; Wo HT; Chen TH; Wu D; Lin FC; Wang CC
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):454-63. PubMed ID: 24251726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined assessment of left ventricular dyssynchrony and contractility by speckled tracking strain imaging: a novel index for predicting responders to cardiac resynchronization therapy.
    Inden Y; Ito R; Yoshida N; Kamiya H; Kitamura K; Kitamura T; Shimano M; Uchikawa T; Tsuji Y; Shibata R; Hirai M; Murohara T
    Heart Rhythm; 2010 May; 7(5):655-61. PubMed ID: 20156618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy.
    Soliman OI; Theuns DA; Geleijnse ML; Anwar AM; Nemes A; Caliskan K; Vletter WB; Jordaens LJ; Cate FJ
    Europace; 2007 Feb; 9(2):113-8. PubMed ID: 17218390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pacing leads.
    Rickard J; Johnston DR; Price J; Tedford R; Baranowski B; Bassiouny M; Cantillon D; Grimm RA; Tang WHW; Varma N; Wilkoff BL
    Heart Rhythm; 2015 Mar; 12(3):517-523. PubMed ID: 25460866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.